Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Adefovir and Lamivudine Combination Therapy in Patients With Entecavir Resistance

NCT01546116 is registered in ClinicalTrials.gov with Korea University as lead sponsor.

NCT NCT01546116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01546116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Adefovir and Lamivudine Combination Therapy in Patients With Entecavir Resistance
Lead sponsor
Korea University
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2010
Completion date
February 28, 2014
Enrollment
20 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b